Filana Therapeutics, Inc. Current Assets
Filana Therapeutics, Inc. (FLNA) had Current Assets of $87.96 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-05-07
- 2026-03-31: Assets, Current $87.96M.
- 2025-12-31: Assets, Current $97.71M.
- 2025-09-30: Assets, Current $108.91M.
- 2025-06-30: Assets, Current $114.82M.
| Period end | Assets, Current |
|---|---|
| 2026-03-31 | $87.96M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $97.71M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $108.91M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $114.82M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $120.15M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $136.53M 10-K · filed 2026-03-12 |
| 2024-09-30 | $202.55M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $222.12M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $134.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $129.63M 10-K · filed 2025-03-03 |
| 2023-09-30 | $150.18M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $174.53M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $195.00M 10-Q · filed 2023-05-01 |
| 2022-12-31 | $211.23M 10-K · filed 2024-02-28 |
| 2022-09-30 | $183.27M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $204.20M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $222.20M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $244.48M 10-K · filed 2023-02-28 |
| 2021-09-30 | $251.91M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $279.56M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $283.77M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $93.99M 10-K · filed 2022-03-01 |
| 2020-09-30 | $25.07M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $25.44M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $25.88M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $23.35M 10-K · filed 2021-03-23 |
| 2019-09-30 | $18.19M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $18.58M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $19.27M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $20.04M 10-K · filed 2020-03-26 |
| 2018-09-30 | $20.72M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $9.70M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $10.89M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $10.66M 10-K · filed 2019-03-29 |
| 2017-09-30 | $12.20M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $14.08M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $17.39M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $19.07M 10-K · filed 2018-02-06 |
| 2016-09-30 | $22.22M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $24.74M 10-Q · filed 2016-07-19 |
| 2016-03-31 | $28.41M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $31.69M 10-K · filed 2017-03-07 |
| 2015-09-30 | $35.41M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $37.50M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $39.37M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $40.83M 10-K · filed 2016-03-03 |
| 2014-09-30 | $43.51M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $45.31M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $47.24M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $50.10M 10-K · filed 2015-02-18 |
| 2013-09-30 | $51.42M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $52.85M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $54.52M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $56.51M 10-K · filed 2014-02-05 |
| 2012-09-30 | $92.91M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $94.04M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $96.37M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $98.49M 10-K · filed 2013-02-08 |
| 2011-09-30 | $100.08M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $101.96M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $98.48M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |